Ligand Announces OmniAb Partnership with iMetabolic Biopharma Corporation
SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has entered into a worldwide OmniAb partnership with iMetabolic Biopharma…
Ligand Announces OmniAb Partnership with iMetabolic Biopharma Corporation Read More »